Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dlbs1033 (1 trial)
Cerebral Infarction (Phase 3)
Infarction (Phase 3)
Ischemia (Phase 3)
Stroke (Phase 3)
Trials (1 total)
Trial APIs (1 total)